UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000002782
Receipt number R000003383
Scientific Title A Randomized controlled study to evaluate the efficacy on male lower urinary tract symptoms with overactive bladder of alpha 1-adrenoceptor antagonist in monotherapy and combination therapy with Eviprostat
Date of disclosure of the study information 2009/12/25
Last modified on 2012/11/19 13:30:12

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A Randomized controlled study to evaluate the efficacy on male lower urinary tract symptoms with overactive bladder of alpha 1-adrenoceptor antagonist in monotherapy and combination therapy with Eviprostat

Acronym

A Randomized controlled study to evaluate the efficacy on male lower urinary tract symptoms with overactive bladder of alpha 1-adrenoceptor antagonist in monotherapy and combination therapy with Eviprostat

Scientific Title

A Randomized controlled study to evaluate the efficacy on male lower urinary tract symptoms with overactive bladder of alpha 1-adrenoceptor antagonist in monotherapy and combination therapy with Eviprostat

Scientific Title:Acronym

A Randomized controlled study to evaluate the efficacy on male lower urinary tract symptoms with overactive bladder of alpha 1-adrenoceptor antagonist in monotherapy and combination therapy with Eviprostat

Region

Japan


Condition

Condition

Male lower urinary tract symptoms with overactive bladder

Classification by specialty

Urology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To verify the efficacy and safety of Eviprostat and alpha 1-adrenoceptor antagonist compared with alpha 1-adrenoceptor antagonist in patients with male lower urinary tract symptoms with overactive bladder

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

To evaluate by using Questionnaires for urinary symptoms(IPSS and OABSS) at 4,8 and 12 weeks.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Harnal(0.2mg daily) for 12weeks

Interventions/Control_2

EviprostatDB (3 tablets daily) and Harnal(0.2mg daily)for 12weeks.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

50 years-old <=

Age-upper limit

80 years-old >

Gender

Male

Key inclusion criteria

1. 50 <or= age < 80
2.IPSS >or= 8, IPSS-QOL >or= 2
3. OABSS(Q3)>or= 2,OABSS(TOTAL) >or= 3

Key exclusion criteria

1. Patients taking medications considered likely to affect micturition
2. PSA>10ng/ml, Patients who suspected prostate cancer
3. Patients who suspected neurogenic bladder
4. Patients with urethral stricture
5. Patients with chronic prostatitis or active urinary tract infenction
6. Patients with previous surgery for BPH
7.Patients with previous intrapelvic radiation
8. Complications considered likely to affect micturition(bladder neck constriction,bladder calculus,urinary calculus, cerebrovascular disease etc).
9. Patients with severe hepatic disorders,severe renal dysfunction and severe cardiovascular disease
10. Patients with performing intermittent catheter insertion themselves
11. Patients with orthostatic hypotension
12.Patients taking OTC medication and dietary supplement considered likely to affect micturition

Target sample size

120


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hiromitsu Mimata

Organization

Oita University Faculty of Medicine

Division name

Department of Urology

Zip code


Address

Idaigaoka 1-1 , Hazama-cho, Yufu-City, Oita, Japan

TEL

097-549-4411

Email



Public contact

Name of contact person

1st name
Middle name
Last name Yasuhiro Sumino

Organization

Oita University Faculty of Medicine

Division name

Department of Urology

Zip code


Address


TEL


Homepage URL


Email



Sponsor or person

Institute

Oita University Faculty of Medicine,Department of Urology

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2009 Year 12 Month 25 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2009 Year 02 Month 05 Day

Date of IRB


Anticipated trial start date

2009 Year 04 Month 01 Day

Last follow-up date

2011 Year 12 Month 01 Day

Date of closure to data entry

2012 Year 03 Month 01 Day

Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2009 Year 11 Month 19 Day

Last modified on

2012 Year 11 Month 19 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000003383


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name